Title : Di'ao Xinxuekang Capsule Improves the Anti-Atherosclerotic Effect of Atorvastatin by Downregulating the SREBP2/PCSK9 Signalling Pathway.

Pub. Date : 2022

PMID : 35571088






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 However, statins can also upregulate proprotein convertase subtilisin/kexin type 9 (PCSK9), which in turn might limits the cholesterol-lowering effect of statins through the degradation of LDL receptors (LDLR). Cholesterol low density lipoprotein receptor Mus musculus
2 However, statins can also upregulate proprotein convertase subtilisin/kexin type 9 (PCSK9), which in turn might limits the cholesterol-lowering effect of statins through the degradation of LDL receptors (LDLR). Cholesterol low density lipoprotein receptor Mus musculus